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PREVIOUS studies of the metabolism of pyrene and 3: 4-benzpyrene have
been reported (Harper, 1957a, 1958a, 1958b, 1958c). This work confirmed the
earlier finding of Weigert and Mottram (1946) that, following injection of 3: 4-
benzpyrene into mice, two metabolic fractions, designated as X1 and X2, are
excreted in the bile and undergo conversion to phenolic derivatives during passage
through the intestine. These two fractions were identified respectively as
sulphuric acid (X1) and glucuronic acid (X2) esters of fully aromatic benzpyrenols
(Harper, 1958b, 1958c) and a similar sequence of conjugation and hydrolysis was
established for the 3-pyrenol metabolite of pyrene (Harper, 1958a, 1958c). Also
associated with the glucuronide fractions yielded by both pyrene and 3: 4-
benzpyrene was an acid-decomposable precursor of the parent hydrocarbon.
This work has nowm been extended to a range of hydrocarbons, namely 1 :2-
benzanthracene, chrysene, 20-methylcholanthrene, 1: 2: 5: 6-dibenzanthracene
and anthracene, utilising the same extraction and analytical procedures. Full
details of these are to be found in the above publications.
MATERIALS AND METHODS
20-Methylcholanthrene (Hoffmann-La-Roche and Co. Ltd.) and anthracelne
(B.D.H. Ltd.) were used as purchased; the other hydrocarbons were purified
by chromatography on alumina from benzene and cyclohexane followed by
fractional crystallisation from ethanol, aq. ethanol or benzene. Colloidal
solutions of the hydrocarbons were prepared by the method of Boyland (1932).
In the case of 1: 2: 5: 6-dibenzanthracene and chrysene however it was found
necessary to heat both acetone solution and water to 50° C. prior to mixing.
Strong A mice, in batches of about twenty, were injected intravenously with
0.5 mg. of colloidal hydrocarbon and the distribution of metabolites within the
internal organs of the body was then investigated using the same general methods
of extraction and chromatographic separation previously reported for pyrene
and 3: 4 benzpyrene. A modification adopted in the case of faecal metabolites
however was as follows.
The freshly voided faeces were extracted into xylene via acetone (Harper,
1957a) and the xylene passed through a column of silica gel (100/200 mesh) for the
removal of acidic metabolites and much of the colouring matter. The filtrate
from the column was evaporated under reduced pressure, the residue extracted
repeatedly with boiling cyclohexane and the cyclohexane chromatographed onINTERMEDIARY METABOLISM OF POLYCYCLIC HYDROCARBONS
silica gel. Any phenolic metabolite of the hydrocarbon was then retained as a
blue fluorescent zone on the column from which it was readily eluted either with
ethanol or with cyclohexane/benzene mixtures. This procedure was preferred to
chromatography on alumina as used in previous studies owing to the difficulty
experienced in removing small amounts of phenolic derivatives from this
adsorbent.
4'-Hydroxy-1: 2-benzanthracene (4'-benzanthrol) was synthesised by the
method of Sempronj (1939). 4'-Methoxy-1:2-benzanthracene was prepared
from this by methylation using dimethyl sulphate and excess sodium hydroxide,
the reaction being continued until the bright golden yellow fluorescence of the
solution had disappeared.
1-Anthrol was prepared by reduction of 9: 10-anthraquinone-l1-sulphonic acid
followed by alkali fusion.
The reference conjugates, 4'-benzanthryl glucuronide and sulphate and
1-anthryl glucuronide and sulphate, were isolated from the bile and small
intestines of mice injected with the parent phenols (cf. Harper, 1958c).
RESULTS
Three hydrocarbons, 1 :2-benzanthracene, chrysene and 20-methylcholan-
threne, yielded well defined blue fluorescent X1 and X2 type metabolites. Excre-
tion was mainly via the bile and hydrolysis to phenolic derivatives and, in the
case of 20-methylcholanthrene, also to an acidic derivative, occurred in the
caecum and large intestine. Blue fluorescent X1 and X2 type metabolites were
also isolated from the bile and small intestine after injection with dibenzanthracene
but the yields of these were greatly reduced by comparison with the other
hydrocarbons. In marked contrast to this behaviour, however, was the failure
of anthracene to yield any material that was recognisable as a metabolite under
the same conditions of extraction and analysis.
The X1 type metabolites were readily hydrolysed by cold dilute mineral acid
and by takadiastase. 8-Glucuronidase was without effect. The X2 type meta-
bolites on the other hand, were unaffected by treatment with mineral acid in the
cold but hydrolysis occurred on prolonged heating under nitrogen with strong
acid (6N HC1). Rapid hydrolysis also occurred on incubation with,-glucuronidase
but this effect was nullified in the presence of l0-2 M boiled saccharate solution.
In view of these properties, and by analogy with the behaviour of the
conjugates of 3-pyrenol and benzpyrenols (Harper, 1958c), the two metabolic
fractions were concluded to be sulphuric and glucuronic acid esters respectively.
The essential problem therefore was the identification ofthe hydrocarbon moieties
of the conjugates.
(A) 1: 2-Benzanthracene
The identification of the phenolic derivative of 1I: 2-benzanthracene excreted
in the faeces of rats and mice was achieved by methylation and spectroscopic
comparison with known methoxy-benzanthracenes (Berenblum and Schoental,
1943). On this basis the 4'-methoxy derivative was selected as being identical
with the methylated metabolite although the presence of absorbing impurity
limited comparison to the long wave systems (above 300 m,) of the absorption
spectra. A characteristic feature of the spectrum was a band at 391.5 m,t in
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hexane but, perhaps surprisingly, the graphical data reported for the methylated
metabolite does not include the sharp prominent maximum at 311-5 m,u (Fig. 2).
In the present work attempts have been made to confirm this identification
by comparison of the conjugated and free phenolic metabolite with the synthetic
analogues derived from 4'-benzanthrol.
(a) The conjugated metabolites
The physical and chemical properties of the X1 and X2 type metabolites were
respectively identical with those of 4'-benzanthryl sulphate and glucuronide.
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Fia. 1. Absorption spectra in ethanol.
1. X1 type metabolite of benzanthracene (b ordinates).
2. 4'-benzanthryl sulphate (a ordinates).
3. 4'-benzanthryl glucuronide (c ordinates).
4. X2 type metabolite of benzanthracene (c ordinates).
The one exception was observed with the X2 type metabolite for, on acid
hydrolysis, a small amount of free 1: 2-benzanthracene was liberated in addition
to a phenolic derivative. The presence of an acid-decomposable precursor of the
hydrocarbon was therefore indicated.
The absorption spectra of the two sets of conjugates are recorded in Fig. 1.
The resemblance between the two types of spectra is at once apparent and
provides confirmatory evidence of the conjugated nature of the hydrocarbon
metabolites. In Table I however are recorded the detailed positions of the
absorption bands and reference to this data reveals that slight differences exist
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in the location of certain bands. (Failure to record a band at or near 308 m,u in
the spectrum ofthe X2type metabolite is possibly due to the presence ofabsorbing
impurity. This was in fact present in one sample ofthe metabolite isolated from
stored bile.)
A possible explanation ofthese differences is that the hydrocarbon metabolites
consistpredominantly ofthe conjugates of4'-benzanthrol but that smaller amounts
of other conjugated derivatives are also present. In the case of the glucuronide
fraction this could be the hydrocarbon precursor but, as the sulphate yields only
a phenolic fraction on hydrolysis, the presence of an additional benzanthrol is
indicated.
(b) The phenolic metabolite
The phenolic derivative of 1: 2-benzanthracene isolated from the faeces
could not be obtained free from absorbing impurity and this prevented complete
characterisation by absorption spectroscopy. In the long wave region above
320 m, however, bands characteristic of 4'-benzanthrol were present and con-
sistent with this behaviour was the bright golden yellow fluorescence exhibited
by the metabolite in sodium hydroxide. In view ofthepossibility ofan additional
benzanthrol being present the metabolite was subjected to methylation and
chromatographic fractionation in the manner described for methoxybenzpyrenes
(Harper, 1958b). No marked differences were observed in the spectra of the
fractions thus obtained and, on pooling and concentrating in vacuo, the absorp-
tion spectrum shown in Fig. 2 was recorded. Also shown inFig. 2 is the spectrum
of the phenolic derivative liberated from the sulphate conjugate by mild acid
hydrolysis and the two are compared respectively with those of 4'methoxy- and
4'-hydroxy-1 2-benzanthracene. The detailed positions of the absorption
bands are given in Table I.
TABLE I
Absorption bands in ethanol (m y) Absorption bands in hexane (m ,)
BAX1 4'-BA-S BAX2 4'-BA-G . BA-OH 4'-OH BA-OMe t'-OMe
-. .. .-- 226 230 228 231
[246-248] [244-248] - 244-246 - 245 246 245-246
252 254 - 254 . 253 253-5 250-254 253-5
-.... - - [262] -
270 272 - - . [270-272] - - -
280 282 - [284-286] [278-280] 277 [280-282] 277
290-291 292 288 288 . 286 286 287-288 287-5
. - 297 297 - 299
- - - 308 - 309.5 - 311-5
324 326 - 328 [320-324] 326-327 [326-328] 327
337
342 342 [338-342] 342 . [340-341] 342 342 342-5
- 354-356 . 354-355 353 354 352-353
358 359 [358-362] 358-360 . - 359 [358-360] 359-360
- 366-368 - 370 . 372 371-372 370-372 371
.... -~~~ . -- 382 - 381
388 389 392 391-392 . 394 392 392 391.5
BAX1 and BAX2 = X1 and X2 metabolites of 1: 2-benzanthracene.
4'-BA-S and 4'-BA-G = sulphuric (S) and glucuronic (G) esters of 4'-benzanthrol.
BA-OH -= free phenolic component of the sulphate conjugate (BAX1).
BA-OMe = methylated faecal metabolite.
4'-OH and 4'-OMe = free (- OH) and methylated (-OMe) 4'-benzanthrol.
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Reference to this data reveals that, above 320 m,t, the spectra of the
methylated metabolite and 4'-methoxy-1: 2-benzanthracene are very similar
and is in agreement with the conclusion of Berenblum and Schoental (1943) that
hydroxylation of the benzanthracene nucleus occurs in the 4'-position. It will
be recalled that this wave length region only was utilised by these workers for
their analysis. In the present work however, the full absorption spectra have
been recorded and below 320 m, it is at once apparent that marked differences
exist. The major band of 4'methoxy-1 2-benzanthracene at 287 m, is present
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FIG. 2.-Absorption spectra in hexane.
1. Phenolic component of the X1 type metabolite of benzanthracene (b ordinates).
2. Methylated faecal metabolite (b ordinates).
3. 4'-benzanthrol (a ordinates).
4. 4'-methoxybenzanthracene (c ordinates).
in the "metabolic" spectrum but a conspicuous feature is the absence of any
band, other than a slight inflection, at 311.5 m,u. The latter is a prominent
feature of the 4'- substituted derivatives and is readily detected in all metabolic
studies with these compounds. It is doubtful therefore that failure to record
this band is due to the presence of masking impurity of natural origin: A
possible explanation is that the presence of an additional related methoxylated
benzanthracene interferes with the absorption of the 4'-methoxy derivative in
this region although chromatographic fractionation revealed no evidence of this.
Support for this proposal however is provided by the spectrum of the free phenol
liberated from the sulphate conjugate. This is similar to that of 4'-benzanthrol
in its general appearance but differences exist in both short and long wave
regions. An unknown phenolic derivative with bands at 226, 286, 297, 320-324,
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337, 354-355, 372, and 394 m,t would indeed appear to represent the major
component of the mixture.
In conclusion, therefore, it can be said that the evidence obtained in this
work is consistent with the view that a mixture ofphenolic derivatives is formed
as a result of the biological hydroxylation of 1: 2-benzanthracene in the mouse.
One of them is 4'-benzanthrol, the other is neither 3-benzanthrol (Jones, 1945)
nor 9: 10-dihydroxy-1: 2: -benzanthracene (Berenblum and Schoental, 1943)
and is as yet unidentified. By analogy with other hydrocarbons however it may
logically be expected to be the 2'-hydroxy derivative.
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FIG. 3.-Absorption spectra in ethanol.
1. Phenolic metabolite of chrysene (b ordinates).
2. X1 type metabolite of chrysene (a ordinates).
3. X2 type metabolite of chrysene (a ordinates).
(B) Chrysene
The phenolic derivative excreted in the faeces after intraperitoneal injection
of chrysene in the rat was identified by Berenblum and Schoental (1949) as
3-chrysenol. Attempts to confirm this in the present work with mice have been
only partially successful owing to the low yield obtained and difficulty experienced
in purification. The experiments have shown however that the two conjugated
fractions yield what appears to be the same chrysenol on hydrolysis with
takadiastase and f/-glucuronidase respectively and that a small amount of free
chrysene is also liberated from the glucuronide fraction on hot acid hydrolysis.
The absorption spectra of the metabolites (Fig. 3), although ill-defined, are
consistent with a fully aromatic chrysenoid configuration. The conjugated
metabolites are therefore concluded to be (3)-chrysenyl sulphate and glucuronide
respectively.
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(C) 20-Methylcholanthrene
This hydrocarbon (I) was ofparticular interest in its divergence from the fully
aromatic configurations so far studied. Although existing evidence on the
2
H$C 7
16~ II5
metabolism of this compound suggested that hydroxylation occurs on the
aromatic benzanthracene nucleus (Cason and Fieser, 1940; Dobriner, Rhoads
and Lavin, 1942), general metabolic considerations were in favour of both phenol
Wavelengthinm/.
FIG. 4.-Absorption spectra in ethanol.
1. Carboxylic acid metabolite of 20-methylcholanthrene (a ordinates).
2. Phenolic metabolite of 20-methylcholanthrene (a ordinates).
3. X1 type metabolite of 20-methylcholanthrene (b ordinates).
4. X2 type metabolite of 20-methylcholanthrene (c ordinates).
and carboxylic acid formation. The latter may be expected to arise from the
oxidation of the attached methyl group-cf. the metabolism of 2-methylnaph-
thalene (Grimes and Young, 1956)--or from fission of the 15-16 bond-cf. the
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metabolism of acenaphthene (Chang and Young, 1943). This theoretical
prediction has been borne out experimentally for two methylcholanthrene
derivatives, one phenolic and the other acidic, have been isolated in this work.
These were absent from the bile and small intestine but were present in the
caecum, large intestine and faeces.
The phenolic derivative possessed normal chromatographic behaviour and
the typical fluorescence colour change from blue to yellow occurred on the
addition ofsodium hydroxide to its ethanolic solution. The absorption spectrum
shown inFig. 4possessed bands at 284, 294, 304-305, 344-346, [352], 363 [378-380]
and 398 m,. It has not been possible to identify it but, by analogy with other
hydrocarbons, it may logically be expected to be either the 2- or 4-hydroxy
derivative.
The acidic derivative was not adsorbed on silica gel from xylene or benzene
but was tightly held as a narrow blue fluorescent zone at the surface ofan alumina
column. Elution was achieved with ethanol containing 1 per cent hydrochloric
acid, ethanol by itself being ineffective. A solution of the metabolite in this
mixture possessed a yellow fluorescence which changed to bright blue on making
alkaline with sodium hydroxide. Its acidic nature was further emphasised by
its solubility in dilute sodium bicarbonate. In view of these properties the
metabolite was concluded to be a carboxylic acid derivative. As the absorption
spectrum shown in Fig. 4, with bands at 284, 295, 302, 312, 334, 348-350, 364-366,
378-380 and 402 m,, establishes the integrity of the aromatic benzanthracene
nucleus, three possible structures for the metabolite are:
(a) Cholanthrene-20-carboxylic acid (II), arising from oxidation of
the methyl group.
(b) 6-Methyl-1: 2-benzanthracene-5: 10-dicarboxylic acid (III), arising
from fission at the 15-16 bond.
or
(c) 1: 2-Benzanthracene-5: 6: 10-tricarboxylic acid (IV), arising from
a combination of these.
II III IV
If the metabolite is either the di-(III) or tri-(IV) carboxylic acid, then
anhydride formation is theoretically possible. This was tested by heating the
compound at 200° C. for ten minutes. After cooling and dissolving in ethanol
no difference in its chromatographic behaviour and absorption spectrum was
observed. A tentative conclusion therefore is that the metabolite is cholanthrene-
20-carboxylic acid (II).
The absence of the free phenol and carboxylic acid from the gall bladder and
small intestine indicated their formation from the conjugated metabolites present
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in these organs. This was confirmed on enzymatic hydrolysis of the conjugates
when the sulphate fraction yielded free phenol alone whilst the glucuronide
fraction yielded a mixture of phenol and carboxylic acid. In the latter case
advantage was taken of the differential solubilities of the derivatives in sodium
bicarbonate to effect a ready separation of the two components from solution
in ether. The same behaviour was observed on acid hydrolysis under nitrogen
but a further phenomenon recorded in this instance was the liberation of a trace
amount of 20-methylcholanthrene from the glucuronide fraction.
The absorption spectra of the conjugated fractions, shown in Fig. 4,
establish that the aromatic benzanthracene nucleus is intact. It is concluded
from this work therefore that the X1 type metabolite is a sulphuric acid ester of a
phenolic derivative of 20-methylcholanthrene whilst the X2 type contains a
mixture of glucuronic acid esters of the same phenol and cholanthrene-(20)-
carboxylic acid together with an acid-decomposable precursor of the hydro-
carbon. Indications of the presence of other water soluble metabolites have also
been obtained but these have not been pursued further.
(D) 1: 2: 5: 6-Dibenzanthracene
A phenolic derivative, 4': 8'-dihydroxy-1 : 2: 5: 6-dibenzanthracene, was the
first metabolite of 1I: 2: 5: 6-dibenzanthracene to be identified (Cason and
Fieser, 1940; Dobriner, Rhoads and Lavin, 1942). Subsequent investigation by
Heidelberger and his collaborators in the United States established that the
metabolism of this hydrocarbon is accompanied by extensive degradation of the
aromatic nucleus (Heidelberger and Jones, 1948; Heidelberger, Kirk and
Perkins, 1948) and consistent with this finding is the low yield of fluorescent
material which has been isolated in the present work. Owing to the small
amounts of metabolites obtained it has not been possible to characterise the
compounds individually by absorption spectroscopy although a mixture of the
conjugated derivatives extracted from bile possessed absorption indicative of an
intact dibenzanthracene nucleus.
Enzymatic hydrolysis of the two conjugated fractions as described resulted
in the liberation of a phenolic derivative as adjudged by the fluorescence colour
change from blue to yellow occurring on the addition of sodium hydroxide. It
was concluded from this behaviour therefore that a phenolic derivative,
presumably 4': 8'-dihydroxy-dibenzanthracene, is excreted via the bile in
conjugation with sulphuric and glucuronic acids. The conjugates could not be
detected within the liver or kidney and were absent from the caecum and large
intestine. Free phenol was present in the latter organs, however, suggesting that
hydrolysis of the conjugates occurs at this site.
These findings are supported by the data reported by Heidelberger, Kirk and
Perkins (1948) on the excretion of l4C-labelled dibenzanthracene following
intravenous injection in the mouse. The extraction procedure adopted by these
workers enabled the radioactivity of the material under investigation to be split
into four fractions which they considered to contain respectively:
(1) Unchanged hydrocarbon.
(2) Unconjugated material.
(3) Extremely water soluble organic substances together with some
less soluble material which was conjugated with water solubilising groups.
(4) A solid residue which was partly soluble in water.
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Analysis of the data obtained respectively from bile and faeces shows that,
during passage through the intestine, there is a transfer of radioactivity from
fraction 3, the major component of the biliary activity, to fractions 2 and 4.
The increase in fraction 2 is most pronounced, from 0.7 per cent in the bile to
14 per cent in the faeces, suggesting that unconjugated derivatives in the faeces
are derived from conjugated compounds excreted in the bile.
It was further shown by these workers that fraction 2 of the faeces contains
a mixture of phenolic, acidic and neutral components so that the same sequence
of conjugation and hydrolysis presumably occurs with the dicarboxylic acid
degradation products as has been established for cholanthrene-(20)-carboxylic
acid in the present work.
(E) Anthracene
The metabolism ofanthracene was studied by Boyland and Levi (1935, 1936a,
1936b) who reported the excretion in the urine of a perhydroxylated derivative,
1: 2-dihydroxy-1: 2-dihydro-anthracene, both free and conjugated with glu-
curonic acid, an unidentified acid-decomposable precursor of the hydrocarbon
and 1-anthrylmercapturic acid. The latter has since been shown by Knight and
Young (1958) to arise during extraction from the action of mineral acid upon a
precursor designated by the general term "premercapturic acid ".
The excretion of metabolites in the bile has also been reported (Chalmers and
Peacock, 1941; Chalmers, 1957) but these have not been identified.
The present experiments with anthracene have shown that X1 and X2 type
derivatives, analogous to those yielded by the other hydrocarbons studied in
this series, are not formed during the metabolism of this compound. The
isolation of such compounds, i.e. 1-anthryl sulphuric and glucuronic acids, from
the bile following injection of 1-anthrol, under the same conditions of extraction,
established that failure to detect these derivatives during metabolism of the
parent hydrocarbon was not due to defects of the extraction process.
The situation was found to be quite different however when the bile and
aqueous extracts of the duodenum and small intestine were first subjected to
mild acid hydrolysis. Under these conditions an X2 type derivative, identical
with 1-anthrylglucuronic acid, and free anthracene were readily extractable
from the acid solutions. A blue fluorescent chloroform soluble fraction was also
present but this was not investigated further.
As the 2-hydroxy-1: 2-dihydro- 1 -anthrylglucuronic acid excreted in the
urine was found by Boyland and Levi (1936a) to break down readily under the
influence of acid to yield 1-anthrylglucuronic acid, it was concluded from the
above behaviour that this perhydroxylated conjugate is also excreted in the bile
together with an acid-decomposable precursor of anthracene and possibly a
"premercapturic acid ".
DISCUSSION
The investigations reported in this and previous publications were part of a
programme designed to determine the role, if any, played by the metabolism of
polycyclic hydrocarbons in induced carcinogenesis. Should the formation of
the metabolites be implicated in the carcinogenic mechanism or themselves be
the initiators of it-cf. the mode of action of 2-naphthylamine (Bonser, Clayson,
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Jull and Pyrah, 1952)-it was considered necessary that the following require-
ments be fulfilled:
(a) They should be present within the tissues of the body where the
carcinogenic effect is applied.
(b) The same type of metabolites should be formed from all carcino-
genic but not non-carcinogenic hydrocarbons (quantitative factors are
ruled out by the fact that the carcinogenic members exert their effect
when present in only trace amounts).
(c) If themselves the proximate carcinogenic agents then this activity
should be detectable by normal laboratory methods of testing.
Requirement (a) was met by the intermediate X1 and X2 metabolites of
3: 4-benzpyrene previously isolated by Weigert and Mottram (1943). Extension
ofthis work to a range ofhydrocarbons has now shown that similar intermediates
are formed from the non-carcinogenic pyrene, the weakly carcinogenic chrysene
and 1: 2-benzanthracene and the strongly carcinogenic 1: 2: 5: 6-dibenzan-
thracene and 20-methylcholanthrene. These intermediates have been found to
possess a common structure, i.e. phenolic derivatives conjugated with sulphuric
acid (X1) and glucuronic acid (X2), and the association of acid-decomposable
precursors of the hydrocarbons with the X2 fractions suggests that these too may
contain a glucuronide conjugated hydroxyl group. Indeed, the experiments
with pyrene (Harper, 1957a, 1958a) suggest that, in like manner to the phenolic
conjugates, the glucuronide moiety of the precursors is split off during excretion
for the pyrene precursor in the faeces was then found in association with the
neutral quinone fraction on the chromatogram. Consistent with this behaviour
would be the presence of an a: ,fl-dihydro-ca-hydroxy configuration similar to
that established for the precursor of naphthalene (Boyland and Solomon, 1955).
The metabolisms of 1 : 2: 5: 6-dibenzanthracene and 20-methylcholanthrene
are further complicated by the formation of carboxylic acid derivatives but
this does not appear to be a general feature of the carcinogenic series.
The anomalous behaviour of anthracene must be attributed to the exclusive
process of perhydroxylation, as opposed to that of hydroxylation, operating on
this hydrocarbon. As dihydrodiols appear to undergo conjugation exclusively
with glucuronic acid the failure of anthracene to bring about any significant
increase in the level of ethereal sulphate excretion in the urine (Elson, Goulden
and Warren, 1945) is consistent with the finding that phenol formation does not
occur.
Only in the case of 3: 4-benzpyrene has it been possible to isolate sufficient
of the intermediate metabolites for carcinogenicity testing. These have been
tested singly, in combination with each other and in combination with a co-
carcinogen, croton oil, but in no case has malignant tumour formation been
observed (Harper, 1957b, 1958d). Other hydrocarbon derivatives tested for
activity include the hypothetical metabolites of anthracene, 1- and 2-anthrol.
These were found to be inactive suggesting that the non-carcinogenic nature of
this hydrocarbon is not due to the protective influence of dihydrodiol formation
(unpublished data).
The overall conclusion from this work therefore is that there appears to be no
specific difference in the chemical nature of the metabolites derived respectively
from carcinogenic and non-carcinogenic hydrocarbons. It is unlikely then that
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the known metabolites represent the proximate carcinogenic agents and this is
supported experimentally both by the negative findings of carcinogenic activity
referred to above and by the negative findings reported for phenolic and acidic
metabolites by other workers (e.g. Hartwell, 1951; Heidelberger and Wiest,
1951; Allen, Boyland and Watson, 1956).
Conversely, the formation of similar metabolites from both carcinogenic and
non-carcinogenic hydrocarbons would appear to provide no indication of an
associationofmetabolism withcarcinogenesis. However, oneimportant difference
not yet referred to lies in the position of the hydrocarbon molecule at which
biochemical hydroxylation takes place. This is exemplified by reference to
Table II in which existing data on the chemical reactivities and metabolic hydro-
TABLE II
Metabolic Metabolic
Reactive Reactive positions bonds Carcinogenic
Hydrocarbon positions bonds (phenols) (dihydrodiols) activity
Naphthalene . . . . 1 (2) 1-2 1 (2) 1-2 -
Anthracene . .. 9, 10 2 } (9, 10) - 1-2 - 3-4
Phenanthrene . . . 9, 10 9-10 9-10 (1-2) -
Pyrene .. 3 1-2 3 ..
Chrysene . . . 2 1-2 3 .. +
1: 2-Benzanthracene . . 9, 10 3-4 4' .. +
9 : 10-Dimethyl-1: 2-benzan- 9, 10 3-4 4' .. +
thracene
1:2:5: 6-Dibenzanthracene . 9,10 { 3- 2' 6 } 7-8 2', 6'
3: 4-Benzpyrene . . . 5 (10) 6-7 8, 10, F1 .. +
(5,5:8,5:10) .. +
20-Methylcholanthrene . . 15 (11, 14) 6-7 2 or 4? .. +
(not 15)
Numbers in brackets refer to positions of secondary activity.
xylation of a range of hydrocarbons is summarised. The non-carcinogenic
members, it will be seen, are characterised by a tendency to undergo either
phenol or dihydrodiol formation, the former occurring at the reactive positions
of the molecule and the latter at the reactive bonds. The carcinogenic members
on the other hand are typified by a tendency to undergo phenol formation only
and this occurs, in general, at positions of the molecule which are inert towards
chemical attack. In order to account for this fact that carcinogenic hydro-
carbons are subjected to hydroxylation in these normally inert positions it has
been suggested (Dickens and Weil-Malherbe, 1945; Boyland, 1948, 1950;
Berenblum and Schoental, 1949) that the reactive centres of the carcinogen are
initially blocked by cellular constituents and that, in this bound state, the
"metabolic positions " become activated. An alternative possibility, however,
is that different hydroxylating mechanisms are operative in the metabolism of
carcinogenic and non-carcinogenic hydrocarbons. It is hoped to discuss both
these possibilities in greater detail in a succeeding paper. At present it is
sufficient to say that any association of a known metabolic process with carcino-
genesis most probably lies within or before the primary stage of aromatic
hydroxylation.
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SUMMARY
1. Previous studies of the intermediary metabolism of pyrene and 3: 4-
benzpyrene have been extended to a range of hydrocarbons, namely 1 : 2-
benzanthracene, chrysene, 20-methylcholanthrene, 1: 2: 5: 6-dibenzanthracene
and anthracene. All of these, with the exception of anthracene, have been
found to undergo hydroxylation to phenolic derivatives. These are excreted
mainly via the bile in conjugation with sulphuric and glucuronic acids and
hydrolysis then occurs during passage through the caecum and large intestine.
Consequently it is the free phenols that are detected when investigations are
confined to the faeces alone.
2. Acid-decomposable precursors of the hydrocarbons have been detected in
association with the glucuronide fraction on the chromatogram. The presence
of a glucuronide moiety in the precursors is therefore indicated and experiments
with pyrene suggest that, in like manner to phenolic conjugates, this is split off
during excretion.
3. Evidence has been obtained that 1 : 2-benzanthracene is subjected to
hydroxylation in two positions of the molecule, the 4'- and possibly, by analogy
with other hydrocarbons, the 2'-.
4. 20-Methylcholanthrene has also been found to yield a carboxylic acid
derivative, provisionally identified as cholanthrene-20-carboxylic acid, and
this undergoes the same sequence of glucuronide conjugation and hydrolysis
during excretion as has been established for the phenolic metabolite. The
data reported on the metabolism of 1: 2: 5: 6-dibenzanthracene-9: 10-14C by
Heidelberger, Kirk and Perkins (1948) is considered to be consistent with a
similar behaviour forthe dicarboxylic acidderivatives yielded by this hydrocarbon.
5. It is suggested that the anomalous behaviour of anthracene is due to the
exclusive process of perhydroxylation operating on this hydrocarbon. The
metabolites excreted in the bile have not been isolated but their behaviour
towards mild acid hydrolysis identifies them as 2-hydroxy-1:2-dihydro-1-
anthryl glucuronic acid and an acid decomposable precursor of the hydrocarbon.
6. It is concluded from these studies that the only important difference
between the known metabolisms of carcinogenic and non-carcinogenic hydro-
carbons lies in the positions of the molecule at which hydroxylation initially
occurs. Consequently any association of metabolism with carcinogenesis most
probably lies either within or before this stage.
The expenses of this work were defrayed from a block grant by the British
Empire Cancer Campaign.
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